1 - 10 of 6215 Results
Title
Year
- Faster disease progression in Parkinson’s disease with type 2 diabetes is not associated with increased α‐synuclein, tau, amyloid‐β or vascular pathology2021OPENTitle: Faster disease progression in Parkinson’s disease with type 2 diabetes is not associated with increased α‐synuclein, tau, amyloid‐β or vascular pathologyJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 47Issue #: 7Start Page: 1080End Page: 1091Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/nan.12728Best OA location URL: https://discovery.ucl.ac.uk/10127765/1/nan.12728.pdfCitation Count: 30
- Reply to: “Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1‐Associated Parkinson's Disease”2022OPENTitle: Reply to: “Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1‐Associated Parkinson's Disease”Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1781End Page: 1782Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29131Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9756875Citation Count: 0
- No Evidence That Glucosylsphingosine Is a Biomarker for Parkinson's Disease: Statistical Differences Do Not Necessarily Indicate Biological Significance2022OPENTitle: No Evidence That Glucosylsphingosine Is a Biomarker for Parkinson's Disease: Statistical Differences Do Not Necessarily Indicate Biological SignificanceJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 653End Page: 653Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28935Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8940713Citation Count: 5
-
OPENTitle: Structural basis of polyamine transport by human ATP13A2 (PARK9)Journal Name: Molecular CellPublisher: Elsevier BVVol: 81Issue #: 22Start Page: 4635End Page: 4649.e8Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.molcel.2021.08.017Best OA location URL: http://www.cell.com/article/S1097276521006845/pdfCitation Count: 36
- Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers2018OPENTitle: Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkersJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 15Issue #: 2Start Page: 232End Page: 244Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2018.08.012Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2018.08.012Citation Count: 275
- Levodopa Responsive Dystonia Parkinsonism, Intellectual Disability, and Optic Atrophy Due to a Heterozygous Missense Variant in AFG3L22022OPENTitle: Levodopa Responsive Dystonia Parkinsonism, Intellectual Disability, and Optic Atrophy Due to a Heterozygous Missense Variant in AFG3L2Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13538Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13538Citation Count: 3
-
OPENTitle: Criminal Behavior in Frontotemporal Dementia: A Multimodal MRI StudyJournal Name: Human Brain MappingPublisher: WileyVol: 46Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.70308Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/hbm.70308Citation Count: 0
- Genetic Diversity and Expanded Phenotypes in Dystonia: Insights From Large‐Scale Exome Sequencing2025OPENTitle: Genetic Diversity and Expanded Phenotypes in Dystonia: Insights From Large‐Scale Exome SequencingJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 12Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.70100Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.70100Citation Count: 0
-
OPENTitle: Mechanisms controlling selective elimination of damaged lysosomesJournal Name: Current Opinion in PhysiologyPublisher: Elsevier BVVol: 29Issue #:Start Page: 100590End Page: 100590Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.cophys.2022.100590Best OA location URL: https://doi.org/10.1016/j.cophys.2022.100590Citation Count: 21
- The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation2022OPENTitle: The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylationJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1778Issue #:Start Page: 147781End Page: 147781Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2022.147781Best OA location URL: https://ars.els-cdn.com/content/image/1-s2.0-S0006899322000051-ga1_lrg.jpgCitation Count: 21